forty patients with germ cell cancer ( gcc ) refractory to vinblastine , cisplatin , and bleomycin therapy were treated with etoposide ( e ) , cisplatin +/- bleomycin +/- doxorubicin and were evaluated retrospectively to determine response to treatment .
C0008838
cisplatin
C0279212
cisplatin